Want to join the conversation?
$MSI 2Q15 Q&A: Ferragu from Sanford Bernstein asked about guidance for 3Q15. Q3 guidance, topline clearly over performance vs. expectations, our expectations in Q2 is driving some of that. And from an earnings perspective it's really similar to Q2 and the incremental sales and associated GM driving the EPS range.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?